Search

Displaying results 5361 - 5370 of 10000 in total
  1. Drug

    Tozorakimab

    go.drugbank.com/drugs/DB16473
    Investigational

    history of exacerbations), and NCT06040086 (recruiting; symptomatic COPD with a history of exacerbations). … NCT04170543 (completed with results; diabetic kidney disease), NCT05624450 (recruiting; viral lung infection requiring supplemental oxygen), NCT05742802 (recruiting; long-term study in COPD patients with a

    Synonyms: ) L123>M (121)) CDR-IMGT [8.8.19] (26-33.51-58.97-1, Immunoglobulin G1, anti-(human interleukin 33) (human monoclonal MEDI3506 γ1-chain), disulfide with human monoclonal MEDI3506 λ-chain, dimer
  2. Drug

    Clobetasol

    go.drugbank.com/drugs/DB11750
    ApprovedInvestigationalWithdrawn

    Clobetasol is under investigation for the treatment of Scleroderma. Clobetasol has been investigated for the prevention of Psoriasis and Cutaneous Atrophy Due to Corticosteroids.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A InducersProducts: CLARELUX 500UG/G SCHAU, CLARELUX 500UG/G SCHAUM
  3. Drug

    Avexitide

    go.drugbank.com/drugs/DB14806
    ApprovedInvestigationalWithdrawn

    Avexitide is under investigation in clinical trial NCT02996812 (Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia).

    Categories: Glucagon-Like Peptide 1Synonyms: Exendin 9-39, EXENDIN (9-39)
  4. Drug

    Etofamide

    go.drugbank.com/drugs/DB13258
    Approved

    Etofamide is used as an antiamoebic agent. Etofamide, under the brand name Kitnos, was marketed in Brazil by Pfizer but has been discontinued [L5617].

  5. Drug

    AG0302-COVID19

    go.drugbank.com/drugs/DB16435
    Investigational

    Sponsored by Anges, Inc. in Japan, the AG0302-COVID19 is a DNA-based vaccine that recently completed Phase I/II trials (NCT04527081)[A226813, L30548].

  6. Drug

    Pomisartan

    go.drugbank.com/drugs/DB20188
    Experimental

    Pomisartan is a small molecule drug. The usage of the INN stem '-sartan' in the name indicates that Pomisartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic). … Pomisartan has a monoisotopic molecular weight of 490.24 Da.

  7. Drug

    Milfasartan

    go.drugbank.com/drugs/DB20355
    Experimental

    Milfasartan is a small molecule drug. The usage of the INN stem '-sartan' in the name indicates that Milfasartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic). … Milfasartan has a monoisotopic molecular weight of 554.21 Da.

    Categories: Heterocyclic Compounds, 1-Ring
  8. Drug

    Pegpleranib

    go.drugbank.com/drugs/DB06325
    Investigational

  9. Drug

    Fucose

    go.drugbank.com/drugs/DB15236
    Investigational

    Fucose is under investigation in clinical trial NCT03354533 (Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II).

    Synonyms: L-FUCOSE
  10. Drug

    Etamicastat

    go.drugbank.com/drugs/DB15288
    Investigational

    Etamicastat is under investigation in clinical trial NCT02840565 (Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453).

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring